Jun 2026 (Q2 FY26) — Aug 4, 2026
Viemed Healthcare Q2 FY26 — Record Revenue and Ventilator Patient Growth
Read the full callViemed Healthcare (VMD) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Viemed Healthcare earnings: last reported Tue, 4 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 78.1 | +23.9% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 5.7 | −2.4 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 2.8 | −12.4% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Price
$9.59 +1.16% · +$0.11
Performance +44.0% 1Y
1Y: $6.66 on 17 Oct 2025 → $9.59. High $12.33 (13 Jul 2026), low $6.26 (6 Nov 2025).
- Previous close
- $9.48
- 52-week range
- $6.26 – $12.33
- One year
- +40.00%
Overview
- Symbol
- VMD
- Sector
- Health Care
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
Viemed Healthcare earnings calls (VMD)
Financials
What the filings say
Net profit, year on year: −12% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 58 | 61 | 59 | 63 | 72 | 76 | 75 | 78 |
| Operating profit | 6 | 6 | 4 | 5 | 6 | 8 | 4 | 4 |
| Operating margin | 9.7% | 10.6% | 6.5% | 8.1% | 7.8% | 11.0% | 5.7% | 5.7% |
| Interest | — | — | 0 | 0 | — | — | 0 | 0 |
| Profit before tax | 5 | 6 | 4 | 5 | 5 | 8 | 4 | 4 |
| Tax rate | 29.0% | 29.8% | 26.0% | 34.5% | 29.9% | 27.4% | 32.0% | 28.4% |
| Net profit | 4 | 4 | 3 | 3 | 4 | 6 | 3 | 3 |
| EPS ($ per share) | 0.10 | — | 0.07 | 0.08 | 0.09 | — | 0.07 | 0.07 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 0 | 3 | 9 | 14 | 15 | 19 | 23 | 17 |
| Reserves | 27 | 34 | 66 | 73 | 70 | 79 | 90 | 103 |
| Total liabilities | 21 | 39 | 31 | 23 | 20 | 41 | 44 | 56 |
| Fixed assets | 31 | 55 | 55 | 63 | 68 | 74 | 76 | 79 |
| Total assets | 54 | 83 | 113 | 118 | 117 | 155 | 177 | 199 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 22 | 19 | 35 | 22 | 28 | 45 | 39 | 52 |
| Cash from investing | -5 | -13 | -8 | -20 | -24 | -52 | -31 | -50 |
| Cash from financing | -12 | -3 | -9 | -5 | -15 | 3 | -4 | -6 |
| Net cash flow | 5 | 3 | 18 | -3 | -11 | -4 | 5 | -4 |
| Capital expenditure | -6 | -13 | -13 | -20 | -23 | -26 | -38 | -40 |
| Free cash flow | 16 | 6 | 22 | 3 | 5 | 19 | 1 | 12 |
Insider filings
100 filings between Jan 17, 2026 and Aug 19, 2026.
Open market
decisions to buy or sellPurchases
None
No insider bought shares.
Sales
$1.59M
9 sales by 3 insiders
Compensation
not trading decisions- 48
- Option exercise — converted options into shares
- 20
- Tax withheld — shares kept back by the company to cover tax
Also filed: 23 dispositions to the issuer.
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Moore Michael | — | $1.24M | Mar 20, 2026 |
| Smokoff Timothy | — | $230.0K | Jun 24, 2026 |
| Frazier William | — | $117.2K | Jun 25, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Aug 19, 2026 | Heltz Sabrina Director | Option exercise | 3,757 | — |
| Aug 19, 2026 | Smokoff Timothy Director | Disposition to issuer | 3,757 | $33.6K |
| Aug 19, 2026 | Kaushal Nitin Director | Option exercise | 18,786 | — |
| Aug 19, 2026 | Dobbs Randy E. Director | Option exercise | 16,763 | — |
| Aug 19, 2026 | Heltz Sabrina Director | Option exercise | 15,029 | — |
| Aug 19, 2026 | Dobbs Randy E. Director | Disposition to issuer | 4,191 | $37.5K |
| Aug 19, 2026 | Dobbs Randy E. Director | Option exercise | 4,191 | — |
| Aug 19, 2026 | Smokoff Timothy Director | Option exercise | 3,757 | — |
| Aug 19, 2026 | Heltz Sabrina Director | Disposition to issuer | 3,757 | $33.6K |
| Aug 19, 2026 | Smokoff Timothy Director | Option exercise | 15,029 | — |
| Jun 25, 2026 | Frazier William Chief Medical Officer | Option exercise | 10,000 | $18.1K |
| Jun 25, 2026 | Frazier William Chief Medical Officer | Sale | 10,000 | $117.2K |
| Jun 24, 2026 | Smokoff Timothy Director | Sale | 5,000 | $57.0K |
| Jun 24, 2026 | Smokoff Timothy Director | Sale | 5,000 | $57.8K |
| Jun 24, 2026 | Smokoff Timothy Director | Sale | 5,000 | $57.6K |
| Jun 24, 2026 | Smokoff Timothy Director | Sale | 3,364 | $38.7K |
| Jun 24, 2026 | Smokoff Timothy Director | Sale | 1,636 | $18.8K |
| Mar 20, 2026 | Moore Michael President | Sale | 65,000 | $570.0K |
| Mar 19, 2026 | Moore Michael President | Sale | 40,232 | $370.5K |
| Mar 18, 2026 | Moore Michael President | Sale | 31,570 | $297.4K |
| Jan 29, 2026 | Hoyt Casey Chief Executive Officer | Option exercise | 13,265 | — |
| Jan 29, 2026 | Hoyt Casey Chief Executive Officer | Tax withheld | 13,913 | $104.1K |
| Jan 29, 2026 | Hoyt Casey Chief Executive Officer | Option exercise | 39,795 | — |
| Jan 29, 2026 | ZEHNDER WILLIAM TODD Chief Operating Officer | Disposition to issuer | 8,948 | $66.9K |
| Jan 29, 2026 | ZEHNDER WILLIAM TODD Chief Operating Officer | Option exercise | 8,948 | — |
| Jan 29, 2026 | ZEHNDER WILLIAM TODD Chief Operating Officer | Tax withheld | 11,368 | $85.0K |
| Jan 29, 2026 | Trahan Jeremy General Counsel | Disposition to issuer | 3,591 | $26.9K |
| Jan 29, 2026 | ZEHNDER WILLIAM TODD Chief Operating Officer | Option exercise | 26,842 | — |
| Jan 29, 2026 | Hoyt Casey Chief Executive Officer | Disposition to issuer | 13,265 | $99.2K |
| Jan 29, 2026 | Moore Michael President | Option exercise | 8,947 | — |
| Jan 29, 2026 | Trahan Jeremy General Counsel | Tax withheld | 2,939 | $22.0K |
| Jan 29, 2026 | Trahan Jeremy General Counsel | Option exercise | 10,774 | — |
| Jan 29, 2026 | Cambre Jerome Vice President of Sales | Disposition to issuer | 2,873 | $21.5K |
| Jan 29, 2026 | Cambre Jerome Vice President of Sales | Tax withheld | 2,355 | $17.6K |
| Jan 29, 2026 | Cambre Jerome Vice President of Sales | Option exercise | 8,619 | — |
| Jan 29, 2026 | Frazier William Chief Medical Officer | Disposition to issuer | 778 | $5.8K |
| Jan 29, 2026 | Moore Michael President | Tax withheld | 7,342 | $54.9K |
| Jan 29, 2026 | Frazier William Chief Medical Officer | Option exercise | 778 | — |
| Jan 29, 2026 | Frazier William Chief Medical Officer | Tax withheld | 802 | $6.0K |
| Jan 29, 2026 | Frazier William Chief Medical Officer | Option exercise | 2,334 | — |
| Jan 29, 2026 | Fitzgerald Trae Chief Financial Officer | Disposition to issuer | 3,265 | $24.4K |
| Jan 29, 2026 | Cambre Jerome Vice President of Sales | Option exercise | 2,873 | — |
| Jan 29, 2026 | Fitzgerald Trae Chief Financial Officer | Option exercise | 3,265 | — |
| Jan 29, 2026 | Fitzgerald Trae Chief Financial Officer | Tax withheld | 2,679 | $20.0K |
| Jan 29, 2026 | Fitzgerald Trae Chief Financial Officer | Option exercise | 9,794 | — |
| Jan 29, 2026 | Trahan Jeremy General Counsel | Option exercise | 3,591 | — |
| Jan 29, 2026 | Moore Michael President | Disposition to issuer | 8,947 | $66.9K |
| Jan 29, 2026 | Moore Michael President | Option exercise | 26,842 | — |
| Jan 21, 2026 | Hoyt Casey Chief Executive Officer | Option exercise | 49,597 | — |
| Jan 21, 2026 | Hoyt Casey Chief Executive Officer | Tax withheld | 13,565 | $101.6K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for VIEMED HEALTHCARE, INC.
Free account. Everything above stays public.
Write why you follow VIEMED HEALTHCARE, INC. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading